Bio Key International Inc
BKYI· Nasdaq
Released Apr 2, 2024, during market hours
10-Q filed Jun 14, 2024, 75 days after period end · 0001437749-24-020368
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $2.18M | $2.18M | $1.94M | $1.89M |
| Net Income | -$510.29K | -$1.69M | -$999.40K | -$851.43K |
| EPS Diluted |
Bio Key International Inc · CIK 1019034 · Engraved from SEC EDGAR
| — |
| — |
| — |
| -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.